Crystal Structure of Bimekizumab Fab Fragment in Complex with IL-17F Provides Molecular Basis for Dual IL-17A and IL-17F Inhibition.

Adams, Ralph; Bunick, Christopher G; Lawson, Alastair D G; Gomez, Braulio; Shaw, Stevan.

Afiliação

Adams R; UCB Pharma, Slough, United Kingdom. Electronic address: ralph.adams@ucb.com.
Bunick CG; Department of Dermatology, Yale School of Medicine, Yale University, New Haven, Connecticut, USA; Program in Translational Biomedicine, Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
Lawson ADG; UCB Pharma, Slough, United Kingdom.
Gomez B; UCB Pharma, Smyrna, Georgia, USA.
Shaw S; UCB Pharma, Slough, United Kingdom.

J Invest Dermatol ; 2024 Apr 16.

Article em En | MEDLINE | ID: mdl-38631666